Key content
Ovarian hyperstimulation syndrome and multiple pregnancy risks are the two key complications of assisted reproductive technology (ART) treatment.
There appears to be no direct association between ART treatment and an increased risk of invasive cancer in infertile women, but there may be a small increased risk of borderline ovarian tumours.
There is suggestive, yet unconvincing, evidence that ART treatment may increase several risks, including childhood cancer risk to children.
A slight increase in the risk of some adverse perinatal outcomes following ART treatment may be caused by the underlying fertility problem.
Female age, ovarian reserve markers and previous obstetric history are the best predictors of ART success.
Currently, there is insufficient evidence to recommend the routine use of some of the interventions to improve reproductive outcome.
Learning objectives
To have an overview of different iatrogenic complications for women undergoing ART and the child or children born following ART treatment.
To understand the evidence‐based synopsis of factors affecting ART success.
To appreciate the limited or conflicting nature of available evidence for certain interventions used to maximise ART treatment outcome.
Ethical issues
Should ART treatment be offered to older women?
What are the long‐term safety implications of some of the ‘adjuvants’ used to improve ART success?